Bevacizumab does not increase the risk of remote relapse in malignant glioma
Preclinical evidence and uncontrolled clinical studies suggest an increased risk for distant spread and development of a gliomatosislike phenotype at recurrence or progression of malignant glioma patients treated with bevacizumab (BEV), an antibody to vascular endothelial growth factor (VEGF). Here...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
2011
|
| In: |
Annals of neurology
Year: 2011, Volume: 69, Issue: 3, Pages: 586-592 |
| ISSN: | 1531-8249 |
| DOI: | 10.1002/ana.22336 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ana.22336 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.22336 
|
| Author Notes: | Antje Wick, MD, Nils Dörner, MD, Navina Schäfer, CandMed, Silvia Hofer, MD, Sabine Heiland, PhD, Daniela Schemmer, RN, Michael Platten, MD, Michael Weller, MD, Martin Bendszus, MD, and Wolfgang Wick, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1826785515 | ||
| 003 | DE-627 | ||
| 005 | 20230710095951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221212s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ana.22336 |2 doi | |
| 035 | |a (DE-627)1826785515 | ||
| 035 | |a (DE-599)KXP1826785515 | ||
| 035 | |a (OCoLC)1389739511 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wick, Antje |d 1972- |e VerfasserIn |0 (DE-588)122759869 |0 (DE-627)706032101 |0 (DE-576)293409609 |4 aut | |
| 245 | 1 | 0 | |a Bevacizumab does not increase the risk of remote relapse in malignant glioma |c Antje Wick, MD, Nils Dörner, MD, Navina Schäfer, CandMed, Silvia Hofer, MD, Sabine Heiland, PhD, Daniela Schemmer, RN, Michael Platten, MD, Michael Weller, MD, Martin Bendszus, MD, and Wolfgang Wick, MD |
| 264 | 1 | |c 2011 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 19 November 2010 | ||
| 500 | |a Gesehen am 12.12.2022 | ||
| 520 | |a Preclinical evidence and uncontrolled clinical studies suggest an increased risk for distant spread and development of a gliomatosislike phenotype at recurrence or progression of malignant glioma patients treated with bevacizumab (BEV), an antibody to vascular endothelial growth factor (VEGF). Here we asked whether BEV treatment of recurrent malignant glioma increases the risk of distant or diffuse tumor spread at further recurrence. BEV-treated patients were compared with matched pairs of patients treated without anti-VEGF regimens. T1 contrast-enhanced (T1+c) and fluid-attenuated inversion recovery (FLAIR) images were analyzed using a novel automated tool of image analysis. At the start of the study, 20.5% of BEV-treated and 22.7% of non-BEV-treated patients had displayed distant or diffuse recurrence. Distant or diffuse recurrences were observed in 22% (BEV) and 18% (non-BEV) on T1+c and in 25% and 18% on FLAIR (p > 0.05). The correlation between changes on T1+c and FLAIR at progression was high. The risk of distant or diffuse recurrence at the time of failure of BEV-containing treatments was not higher than with anti-VEGF-free regimens, arguing against a specific property of BEV that promotes distant tumor growth or a gliomatosislike phenotype at recurrence. Ann Neurol 2010;69:586-592 | ||
| 700 | 1 | |a Dörner, Nils Kristofer |d 1979- |e VerfasserIn |0 (DE-588)134103866 |0 (DE-627)560880944 |0 (DE-576)27839342X |4 aut | |
| 700 | 1 | |a Schäfer, Navina |d 1984- |e VerfasserIn |0 (DE-588)1022347845 |0 (DE-627)716955288 |0 (DE-576)362850003 |4 aut | |
| 700 | 1 | |a Hofer, Silvia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heiland, Sabine |e VerfasserIn |0 (DE-588)106732626X |0 (DE-627)818624450 |0 (DE-576)426561368 |4 aut | |
| 700 | 1 | |a Schemmer, Daniela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 700 | 1 | |a Weller, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bendszus, Martin |e VerfasserIn |0 (DE-588)1032676426 |0 (DE-627)738634131 |0 (DE-576)175567697 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of neurology |d Hoboken, NJ : Wiley-Blackwell, 1977 |g 69(2011), 3 vom: März, Seite 586-592 |h Online-Ressource |w (DE-627)325609837 |w (DE-600)2037912-2 |w (DE-576)094422303 |x 1531-8249 |7 nnas |a Bevacizumab does not increase the risk of remote relapse in malignant glioma |
| 773 | 1 | 8 | |g volume:69 |g year:2011 |g number:3 |g month:03 |g pages:586-592 |g extent:7 |a Bevacizumab does not increase the risk of remote relapse in malignant glioma |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ana.22336 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.22336 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221212 | ||
| 993 | |a Editorial | ||
| 994 | |a 2011 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 10 |y j | ||
| 998 | |g 1032676426 |a Bendszus, Martin |m 1032676426:Bendszus, Martin |d 910000 |d 911100 |e 910000PB1032676426 |e 911100PB1032676426 |k 0/910000/ |k 1/910000/911100/ |p 9 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 910000 |d 911100 |e 910000PP121627780 |e 911100PP121627780 |k 0/910000/ |k 1/910000/911100/ |p 7 | ||
| 998 | |g 106732626X |a Heiland, Sabine |m 106732626X:Heiland, Sabine |d 910000 |d 911100 |e 910000PH106732626X |e 911100PH106732626X |k 0/910000/ |k 1/910000/911100/ |p 5 | ||
| 998 | |g 1022347845 |a Schäfer, Navina |m 1022347845:Schäfer, Navina |d 50000 |e 50000PS1022347845 |k 0/50000/ |p 3 | ||
| 998 | |g 134103866 |a Dörner, Nils Kristofer |m 134103866:Dörner, Nils Kristofer |d 910000 |d 911100 |e 910000PD134103866 |e 911100PD134103866 |k 0/910000/ |k 1/910000/911100/ |p 2 | ||
| 998 | |g 122759869 |a Wick, Antje |m 122759869:Wick, Antje |d 910000 |d 911100 |e 910000PW122759869 |e 911100PW122759869 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1826785515 |e 4229053967 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Antje","display":"Wick, Antje","family":"Wick","role":"aut"},{"given":"Nils Kristofer","role":"aut","family":"Dörner","display":"Dörner, Nils Kristofer"},{"display":"Schäfer, Navina","family":"Schäfer","role":"aut","given":"Navina"},{"display":"Hofer, Silvia","family":"Hofer","role":"aut","given":"Silvia"},{"role":"aut","family":"Heiland","display":"Heiland, Sabine","given":"Sabine"},{"role":"aut","display":"Schemmer, Daniela","family":"Schemmer","given":"Daniela"},{"display":"Platten, Michael","family":"Platten","role":"aut","given":"Michael"},{"given":"Michael","family":"Weller","display":"Weller, Michael","role":"aut"},{"given":"Martin","family":"Bendszus","display":"Bendszus, Martin","role":"aut"},{"given":"Wolfgang","family":"Wick","display":"Wick, Wolfgang","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"note":["Gesehen am 08.11.06"],"title":[{"title":"Annals of neurology","subtitle":"official journal of the American Neurological Association and the Child Neurology Society","title_sort":"Annals of neurology"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["325609837"],"zdb":["2037912-2"],"doi":["10.1002/(ISSN)1531-8249"],"issn":["1531-8249"]},"origin":[{"dateIssuedKey":"1977","dateIssuedDisp":"1977-","publisherPlace":"Hoboken, NJ ; New York, NY","publisher":"Wiley-Blackwell ; Wiley InterScience"}],"corporate":[{"display":"American Neurological Association","role":"isb"},{"role":"isb","display":"Child Neurology Society"}],"pubHistory":["1.1977 -"],"disp":"Bevacizumab does not increase the risk of remote relapse in malignant gliomaAnnals of neurology","part":{"pages":"586-592","volume":"69","extent":"7","year":"2011","issue":"3","text":"69(2011), 3 vom: März, Seite 586-592"},"recId":"325609837","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"2011","dateIssuedKey":"2011"}],"id":{"doi":["10.1002/ana.22336"],"eki":["1826785515"]},"recId":"1826785515","physDesc":[{"extent":"7 S."}],"language":["eng"],"title":[{"title":"Bevacizumab does not increase the risk of remote relapse in malignant glioma","title_sort":"Bevacizumab does not increase the risk of remote relapse in malignant glioma"}],"note":["Online veröffentlicht: 19 November 2010","Gesehen am 12.12.2022"],"name":{"displayForm":["Antje Wick, MD, Nils Dörner, MD, Navina Schäfer, CandMed, Silvia Hofer, MD, Sabine Heiland, PhD, Daniela Schemmer, RN, Michael Platten, MD, Michael Weller, MD, Martin Bendszus, MD, and Wolfgang Wick, MD"]}} | ||
| SRT | |a WICKANTJEDBEVACIZUMA2011 | ||